These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35493667)

  • 1. Anti-HIV drug repurposing against SARS-CoV-2.
    Sang P; Tian SH; Meng ZH; Yang LQ
    RSC Adv; 2020 Apr; 10(27):15775-15783. PubMed ID: 35493667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro.
    Bibi S; Khan MS; El-Kafrawy SA; Alandijany TA; El-Daly MM; Yousafi Q; Fatima D; Faizo AA; Bajrai LH; Azhar EI
    Saudi Pharm J; 2022 Jul; 30(7):979-1002. PubMed ID: 35637849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2
    Khan SA; Zia K; Ashraf S; Uddin R; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Apr; 39(7):2607-2616. PubMed ID: 32238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
    Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
    Abdusalam AAA; Murugaiyah V
    Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV.
    Udofia IA; Gbayo KO; Oloba-Whenu OA; Ogunbayo TB; Isanbor C
    Netw Model Anal Health Inform Bioinform; 2021; 10(1):22. PubMed ID: 33786291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitarget
    Albohy A; Zahran EM; Abdelmohsen UR; Salem MA; Al-Warhi T; Al-Sanea MM; Abelyan N; Khalil HE; Desoukey SY; Fouad MA; Kamel MS
    J Biomol Struct Dyn; 2022 Jun; 40(9):4062-4072. PubMed ID: 33317409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases.
    Kumar V; Roy K
    SAR QSAR Environ Res; 2020 Jul; 31(7):511-526. PubMed ID: 32543892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
    Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
    Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanism of non-covalent inhibitor WU-04 targeting SARS-CoV-2 3CLpro and computational evaluation of its effectiveness against mainstream coronaviruses.
    Wu J; Zhang HX; Zhang J
    Phys Chem Chem Phys; 2023 Sep; 25(35):23555-23567. PubMed ID: 37655706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).
    Rothan HA; Teoh TC
    Mol Biotechnol; 2021 Mar; 63(3):240-248. PubMed ID: 33464543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study.
    Gorai S; Junghare V; Kundu K; Gharui S; Kumar M; Patro BS; Nayak SK; Hazra S; Mula S
    ChemMedChem; 2022 Apr; 17(8):e202100782. PubMed ID: 35112482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential protease inhibitors and their combinations to block SARS-CoV-2.
    Abhinand CS; Nair AS; Krishnamurthy A; Oommen OV; Sudhakaran PR
    J Biomol Struct Dyn; 2022 Feb; 40(2):903-917. PubMed ID: 32924827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19.
    Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M
    Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods.
    Singh E; Khan RJ; Jha RK; Amera GM; Jain M; Singh RP; Muthukumaran J; Singh AK
    J Genet Eng Biotechnol; 2020 Nov; 18(1):69. PubMed ID: 33141358
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro.
    Ferreira JC; Fadl S; Ilter M; Pekel H; Rezgui R; Sensoy O; Rabeh WM
    FASEB J; 2021 Aug; 35(8):e21774. PubMed ID: 34324734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
    Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
    Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.